Common Chemotherapy Drugs--Doxorubicin
Links shared publicly online about this topic.
- 770total visits
Common Chemotherapy Drugs--Doxorubicin
View full resource at suite101.com
Tags: Chemotherapy, Drug, Science
Most Recently Shared on October 28, 2010 at 1:25 am By:
Common Chemotherapy Drugs--Doxorubicin: Doxorubicin is a frequently prescribed chemotherapy drug. As with any chem... http://bit.ly/99jfjm
David Casarett, M.D.: Overtreatment in Cancer: Common Sense Medicine
huffingtonpost.com — “ASCO's admonition to avoid ineffective treatment is unlikely to constrain the use of chemotherapy in advanced cancer significantly, because although it's good advice, it's difficult to put into practice.” View full resource at huffingtonpost.com
Most Recently Shared on April 9, 2012 at 9:12 pm By:
Overtreatment in Cancer: Common Sense Medicine http://t.co/MfDUcubp via @HuffingtonPost #hpm
Taxane Chemotherapy Resistance Seen In Some Breast Cancer Tumors - QualityPoint Technologies
qualitypointtech.net — “Some breast cancer tumours may be resistant to a common chemotherapy treatment, suggests recent medical research at the University of Alberta. Principal investigator Ing Swie Goping and her team discovered some breast cancer tumours had low levels of certain genes, and that those tumours didn't respond well to taxane chemotherapy, a common treatment used in breast cancer.” View full resource at qualitypointtech.net
Most Recently Shared on March 29, 2012 at 9:00 am By:
Taxane Chemotherapy Resistance Seen In Some Breast Cancer Tumors: Some breast cancer tumours may be resistant to a... http://t.co/djUq2Tr4
Taxane Chemotherapy Resistance Seen In Some Breast Cancer Tumors
medicalnewstoday.com — “Some breast cancer tumours may be resistant to a common chemotherapy treatment, suggests recent medical research at the University of Alberta.Principal investigator Ing Swie Goping and h” View full resource at medicalnewstoday.com
Most Recently Shared on March 29, 2012 at 7:05 am By:
Taxane Chemotherapy Resistance Seen In Some Breast Cancer Tumors http://t.co/878KL5xU #breastcancer
Study: Some breast cancer tumours may not respond to taxane chemotherapy
news-medical.net — “Some breast cancer tumours may be resistant to a common chemotherapy treatment, suggests recent medical research at the University of Alberta.” View full resource at news-medical.net
Most Recently Shared on March 28, 2012 at 10:54 am By:
Study: Some breast cancer tumours may not respond to taxane chemotherapy: Some breast cancer tumours may be resi... http://t.co/TxedXJNW
Combining RNA Interference With Tyrosine Kinase Inhibitors Or Cetuximab Enhances Lung Cancer Therapy
medicalnewstoday.com — “Non-small cell lung cancer (NSCLC), the most common form of lung cancer, is usually treated with surgery and chemotherapy. However, a small group of patients can also be helped by treatment with t” View full resource at medicalnewstoday.com
Most Recently Shared on March 21, 2012 at 8:05 am By:
Combining RNA Interference With Tyrosine Kinase Inhibitors Or Cetuximab Enhances Lung Cancer Therapy: Non-small ... http://t.co/nfOz9EY5
Double whammy: RNAi enhances lung cancer therapy
medicalxpress.com — “Non-small cell lung cancer (NSCLC), the most common form of lung cancer, is usually treated with surgery and chemotherapy. However, a small group of patients can also be helped by treatment with tyrosine kinase inhibitors (TKI). New research published in BioMed Central's open access journal BMC Medicine, ...” View full resource at medicalxpress.com
Most Recently Shared on March 20, 2012 at 11:57 pm By:
Double whammy: RNAi enhances lung cancer therapy http://t.co/EN8Gv6zW
Long-term cognitive effects seen with once-common breast chemotherapy regimen - ONA
oncologynurseadvisor.com — “Cognitive deficits subsequent to breast cancer chemotherapy using cyclophosphamide, methotrexate, and fluorouracil can be long-lasting.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 19, 2012 at 1:06 pm By:
Long-term cognitive effects seen with once-common breast #chemotherapy regimen http://t.co/fTWhCmTW
Taking a pill to fight cancer? Avoid these dangerous drug interactions - Boston.com
bostonglobe.com — “Common cancer treatments nowadays include not just radiation, surgery, and infusion chemotherapy treatments, but also pills that patients take every day for weeks, months, or even years. Many of” View full resource at bostonglobe.com
Most Recently Shared on March 17, 2012 at 1:41 am By:
Taking a pill to fight cancer? Avoid these dangerous drug interactions - Boston Globe http://t.co/m19vtY6l #medicine
Taking a pill to fight cancer? Avoid these dangerous drug interactions - Daily Dose: A Boston Globe blog with health news, advice, and information.
boston.com — “Cancer treatments nowadays include not just radiation, surgery, and infusion chemotherapy treatments, but also pills that patients take every day for weeks, months, or even years. Many of these pills, however, interact with common medications such as acid blockers and antihistamines, rendering the cancer drugs less effective or dangerously potent. The majority of cancer patients taking a particular kind of oral cancer drug, known as kinase inhibitors, were taking other medications that interacte” View full resource at boston.com
Most Recently Shared on March 16, 2012 at 10:21 pm By:
Taking a pill to fight cancer? Avoid these dangerous drug interactions http://t.co/AWzTxPDn #healthcare #medicine #cancer
Biology Researcher on the Verge of a Technological Breakthrough in Drug Creation Process | Biomarker Commons
biomarkercommons.org — “New technology being developed at Florida State University could significantly decrease the cost of drug discovery, potentially leading to increased access to high-quality health care and cancer patients receiving personalized chemotherapy treatments.” View full resource at biomarkercommons.org
Most Recently Shared on March 16, 2012 at 11:16 am By:
Study provides insight into developing new treatment strategies for triple-negative breast cancer
news-medical.net — “A new study by University of Kentucky researchers provides insight into developing new treatment strategies for basal-like breast cancer, commonly known as triple-negative breast cancer. This cancer is associated with early metastasis and resistance to chemotherapy and occurs at women at a younger age.” View full resource at news-medical.net
Most Recently Shared on March 15, 2012 at 6:48 am By:
Study provides insight into developing new treatment strategies for triple-negative breast cancer: A new study b... http://t.co/uDcJkXt5
Are there certain things that make getting primary ovarian insufficiency more likely?
healthtap.com — “Chemotherapy, ovarian surgery, genetics, exposure to radiation would be the most common antecedants.” View full resource at healthtap.com
Most Recently Shared on March 15, 2012 at 3:34 am By:
#HealthTap: Are there certain things that make getting primary ovarian insufficiency more likely? Answer http://t.co/VJzYADTn
New study shows promise for developing new treatments for breast cancer
eurekalert.org — “A new study by University of Kentucky researchers provides insight into developing new treatment strategies for basal-like breast cancer, commonly known as triple-negative breast cancer. This cancer is associated with early metastasis and resistance to chemotherapy and occurs at women at a younger age.” View full resource at eurekalert.org
Most Recently Shared on March 14, 2012 at 3:59 pm By:
New study shows promise for developing new treatments for breast cancer: ( University of Kentucky ) A new study ... http://t.co/23ME1deZ
New study shows promise for developing new treatments for breast cancer
medicalxpress.com — “A new study by University of Kentucky researchers provides insight into developing new treatment strategies for basal-like breast cancer, commonly known as triple-negative breast cancer. This cancer is associated with early metastasis and resistance to chemotherapy and occurs at women at a younger age.” View full resource at medicalxpress.com
Most Recently Shared on March 14, 2012 at 3:21 pm By:
New study shows promise for developing new treatments for breast cancer http://t.co/Q7JNTjZX
Financial hardship common among colon cancer patients
medicalxpress.com — “(HealthDay) -- Nearly 40 percent of patients undergoing adjuvant chemotherapy for stage III colon cancer experience financial hardship, even if they have health insurance coverage, according to research published online March 12 in the Journal of Clinical Oncology.” View full resource at medicalxpress.com
Most Recently Shared on March 13, 2012 at 7:47 pm By:
Financial hardship common among colon cancer patients http://t.co/9Di5WdIp
Advertisement

